Spots Global Cancer Trial Database for sarcoma
Every month we try and update this database with for sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) | NCT03816475 | Myxoid Liposarc... | Hypofractionate... | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program | NCT01772771 | Glioma Hematopoietic a... Malignant Solid... Melanoma Sarcoma | Biospecimen Col... Genetic Testing Medical Chart R... | - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma | NCT00002539 | Sarcoma | filgrastim cisplatin doxorubicin hyd... conventional su... | - 40 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy | NCT02062632 | Esophageal Carc... Hypopharyngeal ... Laryngeal Carci... Lymphoma Mesothelioma Metastatic Mali... Metastatic Mali... Metastatic Mali... Non-Small Cell ... Sarcoma Small Cell Lung... Thymic Carcinom... Thymoma Thyroid Gland C... | Doxepin Hydroch... Placebo Quality-of-Life... Questionnaire A... | 18 Years - | Mayo Clinic | |
| EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma | NCT00006222 | Sarcoma | cilengitide | 18 Years - | National Cancer Institute (NCI) | |
| Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors | NCT05361954 | Cancer Cancer of Pancr... Sarcoma Hepatic Metasta... Solid Tumor | STI-1386 | 18 Years - | Sorrento Therapeutics, Inc. | |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells | NCT02210104 | Melanoma Sarcoma | Ipilimumab Cyclophosphamid... CD4+ T cells | 18 Years - | M.D. Anderson Cancer Center | |
| One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy | NCT00358397 | Tumors | Clostridium nov... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues (SkinAge). | NCT02553954 | Sarcoma | Collection of h... | 18 Years - | Centre Oscar Lambret | |
| Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00002985 | Sarcoma | daunorubicin hy... pegylated lipos... | - | Roswell Park Cancer Institute | |
| Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | NCT00072280 | Sarcoma | dactinomycin cyclophosphamid... etoposide ifosfamide vincristine sul... Conventional Su... MESNA (mercapto... Filgrastim | - 2 Years | Children's Oncology Group | |
| Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | NCT02014337 | Breast Cancer Ovarian Epithel... Sarcoma Non-small Cell ... Carcinoma, Tran... Prostate Cancer Prostatic Neopl... | Mifepristone an... | 18 Years - | Corcept Therapeutics | |
| A Survivorship Care Plan for Gynaecological Cancer Patients | NCT01582906 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | 18 Years - 60 Years | Royal Marsden NHS Foundation Trust | ||
| A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma | NCT00001300 | Sarcoma | doxorubicin ifosfamide mesna | - | National Institutes of Health Clinical Center (CC) | |
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00052754 | Sarcoma | gefitinib | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors | NCT05389462 | Advanced Solid ... | ADCT-601 Gemcitabine | 18 Years - | ADC Therapeutics S.A. | |
| Late Effects of Treatment for Sarcomas in Children | NCT00006515 | Sarcoma | 7 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma | NCT03414229 | Sarcoma | Epacadostat Pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery | NCT01143740 | Sarcoma | RO5045337 | 18 Years - | Hoffmann-La Roche | |
| Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma | NCT00123786 | Sarcoma | Positron Emissi... | 15 Years - | AHS Cancer Control Alberta | |
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00003720 | Sarcoma | semaxanib | 18 Years - | Pfizer | |
| Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma | NCT03896620 | Sarcoma | Preoperative RT Postoperative R... Chemotherapy Surgery | 18 Years - | Medical College of Wisconsin | |
| Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 | NCT00582608 | CNS Cancer Neuroblastoma Sarcoma | 131I-8H9 8H9 | 1 Year - 50 Years | Memorial Sloan Kettering Cancer Center | |
| A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma | NCT01842594 | Sarcoma | Sirolimus and h... | 21 Years - 75 Years | Shin Kong Wu Ho-Su Memorial Hospital | |
| Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas | NCT00005874 | Gastrointestina... Sarcoma Small Intestine... | rubitecan | - | National Cancer Institute (NCI) | |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study | NCT01956019 | Sarcoma | MRI scanning | 18 Years - | The Christie NHS Foundation Trust | |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | NCT05860374 | Sarcoma Carcinoma Breast Cancer Pancreatic Canc... Colorectal Canc... Gastric Cancer Liver Cancer Lung Cancer Gynecologic Can... | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology | |
| TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers | NCT03829436 | Hepatocellular ... Metastatic Cast... Renal Cell Carc... Non-small Cell ... Colorectal Canc... Squamous Cell C... Triple-Negative... Urothelial Carc... Cholangiocarcin... GastroEsophagea... Pancreatic Canc... Sarcoma | Part 1 TPST-112... Part 2 TPST-112... Part 3 TPST-112... Part 4 TPST-112... | 18 Years - | Tempest Therapeutics | |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
| Radiation Therapy as Palliative Treatment of GIST | NCT00515931 | Sarcoma | Radiation thera... | - | University of Helsinki | |
| Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma | NCT00004123 | Sarcoma | Doxorubicin hyd... Conventional su... Intraoperative ... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| QUEST: QUality of Life and Experiences of Sarcoma Trajectories | NCT03441906 | Quality of Life Sarcoma Diagnostic Inte... Diagnostic Path... Care Needs | 18 Years - | Radboud University Medical Center | ||
| Cryoablation for Advanced Bone and Soft Tissue Tumors | NCT05615545 | Sarcoma Cryoablation | Cryoablation | - | Henan Cancer Hospital | |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors | NCT04354064 | Healthy Volunte... Prostate Cancer Head and Neck C... Esophageal Canc... Genitourinary C... Sarcoma Breast Cancer Colon Cancer Gastrointestina... Solid Tumor Can... Lung Cancer Skin Cancer Melanoma | 18 Years - | Washington University School of Medicine | ||
| Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal | NCT01341496 | Sarcoma Melanoma Epithelial Mali... Pleural Maligna... | Epigenetically ... Cyclophosphamid... Celecoxib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | NCT00043979 | Sarcoma | F-18 Fluorodeox... therapeutic all... cyclophosphamid... cyclosporine doxorubicin hyd... etoposide fludarabine pho... melphalan prednisone sirolimus tacrolimus vincristine sul... peripheral bloo... Filgrastim Peripheral Bloo... | 5 Years - 35 Years | National Institutes of Health Clinical Center (CC) | |
| Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. | NCT04367779 | Brain Cancer Meningioma Sarcoma | - | Centre Leon Berard | ||
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | NCT01012362 | Breast Cancer Lung Cancer Colon Cancer Pancreatic Canc... Head and Neck C... Kidney Cancer Sarcoma Hepatocellular ... | Pazopanib Ixabepilone | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| High-Dose Methotrexate in Treating Young Patients With Solid Tumors | NCT00513981 | Brain and Centr... Sarcoma Unspecified Chi... | leucovorin calc... methotrexate mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma | NCT01879085 | Sarcoma | Docetaxel Gemcitabine Vorinostat Pegfilgrastim | 18 Years - | University of Pittsburgh | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| WeCanManage. An mHealth Self-management Tool | NCT06185738 | Breast Cancer Head and Neck C... Sarcoma | WCM app | 18 Years - | University of Illinois at Chicago | |
| An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry | NCT02677961 | Neoplasms, Conn... Bone Neoplasms | Observation | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Assessing Health-related Quality of Life in Sarcoma Patients | NCT04071704 | Sarcoma | 18 Years - | The Netherlands Cancer Institute | ||
| Pemetrexed in Patients With Soft Tissue Sarcoma | NCT00427466 | Sarcoma | Pemetrexed | 18 Years - 90 Years | University Hospital Tuebingen | |
| Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | NCT04541108 | Solid Tumor | Rilvegostomig Volrustomig Sabestomig Pembrolizumab | 18 Years - | Presage Biosciences | |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | NCT02897375 | Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer | Carboplatin Cisplatin Palbociclib | 18 Years - | Emory University | |
| A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors | NCT00001209 | Neuroectodermal... Neuroepitheliom... Osteosarcoma Sarcoma Sarcoma, Ewing'... | vincristine, ad... | - | National Institutes of Health Clinical Center (CC) | |
| Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma | NCT04776525 | Soft Tissue Sar... | Ifosfamide Doxorubicin | 18 Years - | Oslo University Hospital | |
| A Study of PRT1419 in Patients With Advanced Solid Tumors | NCT04837677 | Sarcoma Melanoma Lung Cancer Breast Cancer Esophageal Canc... Cervical Cancer Head and Neck C... | PRT1419 | 18 Years - | Prelude Therapeutics | |
| Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers | NCT00580203 | Head and Neck C... | - | Memorial Sloan Kettering Cancer Center | ||
| DNX-2440 for Resectable Colorectal Liver Metastasis | NCT04714983 | Liver Metastase... Liver Metastasi... Colorectal Canc... Breast Cancer Gastric Cancer Periampullary C... Melanoma Renal Cell Canc... Sarcoma Squamous Cell C... Gastrointestina... | DNX-2440 | 18 Years - | DNAtrix, Inc. | |
| ODSH + ICE Chemotherapy in Pediatric Solid Tumors | NCT02164097 | Recurrent Solid... Refractory Soli... Sarcoma Wilms' Tumor Neuroblastoma | ODSH | 1 Year - 21 Years | New York Medical College | |
| Sorafenib and Dacarbazine in Soft Tissue Sarcoma | NCT00837148 | Sarcoma Synovial Sarcom... Leiomyosarcoma Malignant Perip... | Sorafenib and D... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) | NCT01337401 | Alveolar Soft-p... | Cediranib Placebo | 16 Years - | Institute of Cancer Research, United Kingdom | |
| Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | NCT00096538 | Sarcoma | valganciclovir | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms | NCT00927966 | Sarcoma Solid Tumor | RAD001 CP-751,871 | 18 Years - | Dana-Farber Cancer Institute | |
| Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay | NCT02797405 | Sarcoma Rectal Carcinom... Esophagus Cance... | Standard treatm... | 18 Years - | Centre Leon Berard | |
| Fosaprepitant in Patients Receiving Ifosfamide-based Regimen | NCT01490060 | Sarcoma Chemotherapy-in... Effects of Chem... Adverse Effects... | Fosaprepitant Dexamethasone 5HT3 receptor a... Ifosfamide-base... Doxorubicin Mesna Ifosfamide Vincristine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma | NCT00005625 | Sarcoma | trabectedin | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Oral Darinaparsin in Patients With Advanced Solid Tumors | NCT01139346 | Advanced Solid ... | darinaparsin | 18 Years - | Alaunos Therapeutics | |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
| Stereotactic Radiation Therapy for Pediatric Sarcomas | NCT01763970 | Sarcoma Metastatic Dise... Bony Sites | SBRT | 4 Years - 40 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer | NCT02015416 | Melanoma Ovarian Cancer Sarcoma Non-small Cell ... Breast Cancer | IDC-G305 | 18 Years - 80 Years | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Bevacizumab/Doxorubicin/Radiation for Sarcoma | NCT01746238 | Sarcoma | Bevacizumab Doxorubicin Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
| Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | NCT00003207 | Sarcoma Unspecified Adu... | pegylated lipos... PSC 833 | 18 Years - | Washington University School of Medicine | |
| Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | NCT02988817 | Ovarian Cancer Cervical Cancer Endometrial Can... Non Small Cell ... Thyroid Cancer Melanoma Sarcoma Solid Tumors | Enapotamab vedo... | 18 Years - | Genmab | |
| Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma | NCT00450320 | Sarcoma | sirolimus | 18 Years - | AIDS Malignancy Consortium | |
| Figitumumab Combined With Pegvisomant For Advanced Solid Tumors | NCT00976508 | Colorectal Neop... Lung Neoplasms Breast Neoplasm... Prostatic Neopl... Sarcoma | figitumumab pegvisomant | 10 Years - | Pfizer | |
| Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015) | NCT00288431 | Cancer Sarcoma | ridaforolimus Doxorubicin | 18 Years - | Merck Sharp & Dohme LLC | |
| Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study | NCT03539172 | Soft Tissue and... Head and Neck C... Sarcoma | Apatinib Mesyla... | 10 Years - 75 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment | NCT02812654 | Sarcoma, Soft T... | Doxorubicin Ifosfamide radiotherapy | 18 Years - 75 Years | AC Camargo Cancer Center | |
| Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity | NCT00001577 | Melanoma Sarcoma | double isolated... | - | National Institutes of Health Clinical Center (CC) | |
| S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas | NCT00217620 | Sarcoma | sorafenib | 18 Years - | National Cancer Institute (NCI) | |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | NCT03058289 | Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma | INT230-6 anti-PD-1 antib... anti-CTLA-4 ant... | 18 Years - | Intensity Therapeutics, Inc. | |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus | NCT00005643 | Endometrial Can... Sarcoma | pegylated lipos... | 21 Years - | GOG Foundation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
